ÀÇÎѵ¼º½

Fertility-sparing treatment was used increase the odds of her being able to start a family.

Dr. Shridar Ganesan’s background is in cancer biology and DNA repair.

The CEO and dean of NYU Langone spoke with STAT News about what sets it apart.

Dr. Nikhil Kumta will also serve as an associate professor in the Department of Medicine.

With few viable organs available from donors, a pioneering surgeon explores a bold alternative.

A pioneer in cardio-oncology treats cardiovascular conditions that can result from cancer therapies.

NYU Langone researchers lay the genetic groundwork for predicting an individual’s risk for cancer.

A five-year study finds focal therapy can be effective for intermediate-risk prostate cancer.

Dr. Oscar B. Lahoud was also named a director at Perlmutter Cancer Center.

Dr. Roxana Fu is a leader in innovative approaches in oculoplastic and orbital eye surgery.